James Ferguson

James Ferguson

Directeur Technique/Scientifique/R&D chez CADRENAL THERAPEUTICS, INC.
72 ans
Health Technology
Consumer Services
Health Services

Profil

James J.
Ferguson
is Chief Medical Officer at Cadrenal Therapeutics, Inc. since 2025.
Formerly, Chief Medical Officer at Matinas BioPharma Holdings, Inc. from 2019 to 2024.
Head-Cardiovascular & Bone Therapeutic at Amgen, Inc. from 2016 to 2019.
Vice President-Global Medical Affairs at AstraZeneca PLC from 2010 to 2016.
VP-Global Medical, Surgical & Critical Care at The Medicines Co. from 2009 to 2010.
Associate Director-Clinical Cardiology Research at Texas Heart Institute from 1987 to 2008.
Director-Cardiology Fellowship Training Program at St. Luke's Episcopal Hospital.
Associate Professor at Baylor College of Medicine.
Clinical Assistant Professor at The University of Texas Health Science Center at Houston.
Education includes undergraduate degree from Harvard University and doctorate from the University of Pennsylvania Medical Center.

Postes actifs de James Ferguson

SociétésPosteDébut
CADRENAL THERAPEUTICS, INC. Directeur Technique/Scientifique/R&D 06/02/2025

Anciens postes connus de James Ferguson

SociétésPosteFin
MATINAS BIOPHARMA HOLDINGS, INC. Directeur Technique/Scientifique/R&D 31/10/2024
AMGEN INC. Corporate Officer/Principal 01/01/2019
ASTRAZENECA PLC Corporate Officer/Principal 01/08/2016
THE MEDICINES COMPANY Corporate Officer/Principal 01/05/2010
Corporate Officer/Principal 01/01/2008
Voir l'expérience en détail de James Ferguson

Formation de James Ferguson

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

65

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

Consumer Services

Health Services

Consumer Services

Consumer Services

Health Technology

  1. Bourse
  2. Insiders
  3. James Ferguson
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT